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Background: Acetaminophen overdose is a major concern among the pediatric population. Our objective was to
assess the validity of International Classification of Disease (ICD-9-CM) codes for identification of pediatric
emergency department (ED) visits resulting from acetaminophen exposure or overdose.
Methods: We conducted a retrospective medical record review of ED visits at Texas Children’s Hospital in Houston,
Texas, between January 1, 2005, and December 31, 2010. Visits coded with 1 or more ICD-9 codes for poisoning
(965, 977, and their subcodes and supplemental E-codes E850, E858, E935, E947, and E950 and their subcodes) were
identified from an administrative database, and further review of the medical records was conducted to identify
true cases of acetaminophen exposure or overdose. We then examined the sensitivity, positive predictive value, and
percentage of false positives identified by various codes and code combinations to establish which codes most
accurately identified acetaminophen exposure or overdose.
Results: Of 1,215 ED visits documented with 1 or more of the selected codes, 316 (26.0%) were a result of
acetaminophen exposure or overdose. Sensitivity was highest (87.0%) for the combination of codes 965.4
(poisoning by aromatic analgesics, not elsewhere classified) and E950.0 (suicide and self-inflicted poisoning by
analgesics, antipyretics, and antirheumatics), with a positive predictive value of 86.2%. Code 965.4 alone yielded a
sensitivity of 85.1%, with a positive predictive value of 92.8%. Code performance varied among age groups and
depending on the type of exposure (intentional or unintentional).
Conclusion: ICD-9 codes are useful for ascertaining which ED visits are a result of acetaminophen exposure or
overdose within the pediatric population. However, because ICD-9 coding differs by age group and depending on
the type of exposure, hypothesis-driven strategies must be utilized for each pediatric age group to avoid
misclassification.
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Acetaminophen is the leading pharmaceutical product
consumed in the United States [1]. High use rates raise
concern for accidental exposure and overdose in chil-
dren. The Centers for Disease Control and Prevention
Morbidity and Mortality Weekly Report noted that more
than 50,000 emergency department (ED) visits between
2001 and 2003 were for children younger than 4 years* Correspondence: msalmazor@mdanderson.org
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distribution, and reproduction in any mediumwho were treated for a potential pharmaceutical over-
dose, and most of these children were aged 1 to 2 years.
Despite minimization efforts, ED visits for unintentional
medication exposures persist, and many of these unin-
tentional exposures involve acetaminophen [2].
Reported rates of acetaminophen-related ED visits
among children are commonly extrapolated from the
National Electronic Injury Surveillance System–All In-
jury Program (NEISS-AIP), which contains information
on all injuries treated in the ED at a sample of hospitals
in the United States. The Centers for Disease Control
also collaborates on the NEISS Cooperative Adversetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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all adverse drug events leading to ED visits for children
and teens [3]. According to these data, of all drugs
associated with pediatric overdose resulting in ED visits
in the United States between 2004 and 2005, acetamino-
phen accounted for the highest number of cases of un-
supervised ingestion (10.5% of cases) and the second
highest number of cases of misuse (13.5% of cases) [4].
In addition to these estimates, acetaminophen uninten-
tional pharmaceutical exposure and overdose in children
younger than 6 years is collected from the US Poison
Control Center as a comparator [5]. However, this infor-
mation is voluntarily provided to the call center and thus
may underestimate the rate of pediatric acetaminophen
exposure and overdose because less severe cases may
not require a call. Moreover, the information from the
American Association of Poison Control Centers Na-
tional Poison Data System (AAOCC-NPDS) does not in-
clude medical examinations or final diagnoses. Estimates
of pediatric acetaminophen exposure and overdose are
similar between NEISS and AAPCC however, both may
be underestimates of the rate of accidental pharmaceut-
ical exposure and overdose among children [6].
Pediatric exposure to and overdose from acetamino-
phen has received attention from the US Food and Drug
Administration Center for Drug Evaluation and Re-
search, which has discussed changing dosing information
for over-the-counter products containing acetaminophen
for children younger than 12 years [7]. At the 2011 US
Food and Drug Administration nonprescription advisory
committee meeting, information was presented from
the Nationwide Inpatient Sample for 1998–2008, re-
presenting 95% of all US hospitalizations during that
period. (The Nationwide Inpatient Sample is part of the
Healthcare Cost and Utilization Project, which is
sponsored by the Agency for Healthcare Research and
Quality [7]). These data were collecting using an Inter-
national Classification of Disease (ICD-9) approach. Two
primary codes were used to identify cases of acetamino-
phen exposure or overdose among children: ICD-9
codes 965.4 (poisoning by aromatic analgesics, not else-
where classified [NEC]) and E850.4 (accidental poisoning
by aromatic analgesics, NEC) [7]. Clinical records were
not available for review, and it was assumed that all
cases identified were acetaminophen exposures or
overdoses. This is one of few instances in which ICD-9
codes were explicitly used to identify discharges related
to acetaminophen exposure among children. As no “gold
standard” measures exist and current surveillance and
reporting methods may be flawed, it is important to re-
evaluate and assess novel approaches for estimating acet-
aminophen overdose among the pediatric population [6].
The objective of this study was to evaluate the utility
of various ICD-9 codes or combinations of codes foridentifying ED visits resulting from acetaminophen ex-
posure or overdose among children.
Methods
Data collection
We collected records of ED visits related to acetamino-
phen exposure or overdose between the dates of January
1, 2005, and December 31, 2010, at Texas Children’s
Hospital in Houston, Texas, which has the largest
pediatric ED in south-central Texas, admitting approxi-
mately 85,000 patients each year. Administrative records
of the ED visits documented diagnostic information
using specific ICD-9 codes (Table 1) [8]. We selected
records containing codes related to acetaminophen and
analgesic exposure, specifically codes 965 (poisoning by
analgesics, antipyretics, and antirheumatics), 977 (poi-
soning by other and unspecified drugs and medicinal
substances), or any of the subcodes of 965 or 977. In
addition, we selected records containing certain supple-
mental E-codes or any of their subcodes: E850 (acciden-
tal poisoning by drugs, medicinal substances, and
biological substances), E858 (accidental poisoning by
other drugs), E935 (aromatic analgesics, NEC, causing
adverse effects in therapeutic use), E947 (other and
unspecified drugs and medicinal substances causing ad-
verse effects in therapeutic use), and E950 (suicide and
self-inflicted poisoning by solid or liquid substances). Al-
though the coding algorithms are defined by ‘poisoning’
many cases reviewed did not include poisoning. We
therefore refer to these cases as acetaminophen-related
exposures or overdose. Our search included all diagnos-
tic codes used to document each visit, which at Texas
Children’s Hospital can number up to 25. Demographic
information was collected from the medical record. The
University of Texas MD Anderson Cancer Center and
Baylor College of Medicine Institutional Review Boards
approved this study protocol.
Chart review
A detailed review of the selected medical records was
conducted by trained research assistants to confirm that
the coding accurately reflected cases of pediatric acet-
aminophen exposure or overdose. Each record of the
visit date and consecutive hospital stay, if applicable, was
reviewed by a research assistant. A standardized data ab-
straction worksheet with a detailed codebook was used
for each visit. We defined cases as those in which a
suspected or known accidental ingestion or an overdose
of an acetaminophen-containing product were clearly
documented. We included suspected ingestions because
often a child was found with an open bottle but the
caregiver was not certain whether the child had ingested
any of the contents. The type of acetaminophen expos-
ure or overdose was categorized as unintentional,
Table 1 International Classification of Disease (ICD-9)
codes and supplemental E-codes used to identify
emergency department visits resulting from pediatric
acetaminophen exposure or overdose*
ICD-9 code Description
Regular codes
965.0 Poisoning by opium (alkaloids), unspecified
965.01 Poisoning by heroin
965.02 Poisoning by methadone
965.09 Poisoning by other opiates and related narcotics
965.1 Poisoning by salicylates
965.4 Poisoning by aromatic analgesics, not elsewhere
classified
965.5 Poisoning by pyrazole derivatives
965.61 Poisoning by propionic acid derivatives
965.69 Poisoning by other antirheumatics
965.7 Poisoning by other nonnarcotic analgesics
965.8 Poisoning by other specified analgesics and
antipyretics
965.9 Poisoning by unspecified analgesics and antipyretics
977.0 Poisoning by dietetics
977.1 Poisoning by lipotropic drugs
977.2 Poisoning by antidotes and chelating agents, not
elsewhere classified
977.3 Poisoning by alcohol deterrents
977.4 Poisoning by pharmaceutical excipients
977.8 Poisoning by other specified drugs and medicinal
substances
977.9 Poisoning by unspecified drugs or medicinal
substances
Supplemental codes
E850.0 Accidental poisoning by heroin
E850.1 Accidental poisoning by methadone
E850.2 Accidental poisoning by other opiates and related
narcotics
E850.3 Accidental poisoning by salicylates
E850.4 Accidental poisoning by aromatic analgesics, not
elsewhere classified
E850.5 Accidental poisoning by pyrazole derivatives
E850.6 Accidental poisoning by antirheumatics
(antiphlogistics)
E850.7 Accidental poisoning by other nonnarcotic
analgesics
E850.8 Accidental poisoning by other specified analgesics
and antipyretics
E850.9 Accidental poisoning by unspecified analgesics or
antipyretics
E858.0 Accidental poisoning by hormones and synthetic
substitutes
E858.1 Accidental poisoning by primarily systemic agents
Table 1 International Classification of Disease (ICD-9)
codes and supplemental E-codes used to identify
emergency department visits resulting from pediatric
acetaminophen exposure or overdose* (Continued)
E858.2 Accidental poisoning by agents primarily affecting
blood constituents
E858.3 Accidental poisoning by agents primarily affecting
cardiovascular system
E858.4 Accidental poisoning by agents primarily affecting
gastrointestinal system
E858.5 Accidental poisoning by water, mineral, and uric acid
metabolism drugs
E858.6 Accidental poisoning by agents primarily acting on
the smooth and skeletal muscles and respiratory
system
E858.7 Accidental poisoning by agents primarily affecting
skin and mucous membranes; ophthalmological,
otorhinolaryngological, and dental drugs
E858.8 Accidental poisoning by other specified drugs
E858.9 Accidental poisoning by unspecified drugs
E935.0 Heroin causing adverse effects in therapeutic use
E935.1 Methadone causing adverse effects in therapeutic use
E935.2 Other opiates and related narcotics causing adverse
effects in therapeutic use
E935.3 Salicylates causing adverse effects in therapeutic use
E935.4 Aromatic analgesics, not elsewhere classified, causing
adverse effects in therapeutic use
E935.5 Pyrazole derivatives causing adverse effects in
therapeutic use
E935.6 Antirheumatics [antiphlogistics] causing adverse
effects in therapeutic use
E935.7 Other nonnarcotic analgesics causing adverse effects
in therapeutic use
E935.8 Other specified analgesics and antipyretics causing
adverse effects in therapeutic use
E935.9 Unspecified analgesics and antipyretics causing
adverse effects in therapeutic use
E950.0 Suicide and self-inflicted poisoning by analgesics,
antipyretics, and antirheumatics
E950.5 Suicide and self-inflicted poisoning by unspecified
drugs or medicinal substances
*Boldface type indicates codes that achieved the a priori set threshold of a
positive predictive value ≥ 50%.
de Achaval et al. BMC Health Services Research 2013, 13:72 Page 3 of 8
http://www.biomedcentral.com/1472-6963/13/72intentional, or illicit unintended use. Unintentional acet-
aminophen exposure occurred in cases in which the
caregiver suspected ingestion, a provider gave the child
an incorrect dose, or the child ingested acetaminophen
without an adult’s supervision or intention to treat.
Intentional acetaminophen exposure occurred in cases
in which the patient admitted to intentionally ingesting
the medication with the purpose of harming him or her-
self, or if the treating physician or social worker note
included the key words ‘intentional’ or ‘suicidal use.’
Illicit unintended use of acetaminophen occurred in
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patient admitting to intentionally ingesting the medica-
tion for the purpose of “getting high.” All charts
reviewed with information regarding the visit fell into
one of the previously defined categories. Uncertainties
regarding intention category were reviewed with a sec-
ond chart review and consensus among two reviewers.
Visits identified by the codes that were missing medical
records or did not have any notes regarding the visit
were excluded.
Statistical analysis
We estimated the sensitivity for each ICD-9 code of inter-
est under the assumption that all possible acetaminophen-
related ED visits had been coded by at least 1 of the codes
of interest, implying 100% capture with the codes listed in
Table 1. Sensitivity of a code was estimated as the percent-
age of all cases of acetaminophen exposure or overdose
identified by the code. We also calculated the positive
predictive value (PPV) for each code of interest as the per-
centage of acetaminophen-related visits among all ED
visits identified by that code. In addition, the percentage
of ED visits identified by each code that were later
determined not to be cases of acetaminophen exposure
or overdose was also calculated, determining in the per-
centage of false-positive cases identified by each code.
We report false positive cases and specificity inter-
changeably as specificity is equal to one minus false
positives. The performance of combinations of codes
was also evaluated using sensitivity, PPV, and percent-
age of false positives. These results (for both single
codes and combinations of codes) were then stratified
by age categories that are based on previous research
related to pediatric acetaminophen-related ED visits: all
ages, less than 6 years, ages 6–14 years, and 15 years or
greater [9]. Trends in overdose were compared for all
years. For the final analysis, we included only codes used
for 1 or more visits that had a PPV of at least 50% to
avoid inclusion of codes with a high proportion of false
positives. Codes included in the final analysis are shown
in boldface type in Table 1. PPV and sensitivity were
calculated for these codes within each age group. Data
were analyzed using Stata 10.0 software (StataCorp,
College Station, TX).
Results
Identification of acetaminophen-related ED visits
During the specified timeframe, there were 478,973
admissions to the ED of Texas Children’s Hospital, and
1,215 (0.25%) of these visits were documented with at
least 1 of the relevant ICD-9 codes shown in Table 1. Of
these 1,215 visits (for 1,119 unique patients), 316 visits
(26.0%) were considered to be for cases of potential acet-
aminophen exposure or overdose after review of therecords. Eight hundred ninety-nine visits were not
related to acetaminophen exposure or overdose; we
categorized them broadly into 1 of 3 groups: (1) visits
for drug adverse events without any mention or suspi-
cion of overdose: 40 visits (4.4%); (2) visits for potential
exposure to or overdose from a drug other than acet-
aminophen: 569 visits (63.3%); and (3) visits that did not
appear to be related to drug overdose (in some cases
acetaminophen may have been in the medication list,
but without reference to intoxication or suspicion of
overdose): 290 cases (32.3%). The median age of patients
in the 316 relevant visits was 9.8 years (range 3.6 months
to 20.2 years) and 61.7% were female (Table 2).
ICD-9 code performance
General codes among those selected for this study that
did not achieve the a priori set threshold of PPV ≥ 50%
included 977 (poisoning by other and unspecified drugs
and medicinal substances) and all subcodes of the
following supplemental E-codes: E858 (accidental
poisoning by other drugs), E935 (aromatic analgesics,
not elsewhere classified, causing adverse effects in thera-
peutic use), and E947 (other and unspecified drugs and
medicinal substances causing adverse effects in thera-
peutic use).
Table 3 shows the sensitivity, PPV, and percentage of
false positives for each code and each code combination
with a PPV of at least 50%, by age group. With all ages
considered together, the highest sensitivity, 87.0%, was
observed for the combination of codes 965.4 (poisoning
by aromatic analgesic, NEC) or E950 (suicide and self-
inflicted poisoning by analgesics, antipyretics, and
antirheumatics), with a PPV of 86.2%. The sensitivity for
code E850.4 (accidental poisoning by aromatic anal-
gesics, NEC) in all age groups was low (25.9%), but only
5.7% of the visits documented with this code were false
positives. Only 1 visit was coded with 850.7 (accidental
poisoning by other non-narcotic analgesics), and there-
fore the PPV for this code was 100%. Code 965.4 had a
sensitivity of 85.1% and a PPV of 92.8%. Of note, all
cases of acetaminophen exposure or overdose identified
by code E850.4 were also identified by code 965.4. In
addition, the majority (91.5%) of cases identified by code
E950.0 were also coded as 965.4.
When we included only the codes with a PPV of at
least 50% in our analysis, sensitivity was high. However,
41 (13.0%) of the 316 cases of acetaminophen exposure
or overdose were not identified by these codes. These
cases were identified by codes 965.09 (poisoning by
other opiates and related narcotics; 31.7%), 965.1
(poisoning by salicylates; 12.2%), or 977.8 (poisoning by
other specified drugs and medicinal substances; 9.8%);
13 additional codes identified fewer than 3 cases each.
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after stratification by age group (Table 3). The youngest
group (0–5 years) had the highest number of visits iden-
tified by the specified codes. For age group of 6–14
years, 80.3% of the cases were identified by 965.4, with a
PPV of 91.9%. The code for accidental poisoning by aro-
matic analgesics (E850.4) had the second highest PPV
(77.8%), but the sensitivity was very low (9.9%). Within
this age group, code E950.0 (suicide and self-inflicted
poisoning by analgesics, antipyretics, and antirheu-
matics) identified a considerable proportion of cases,
resulting in a sensitivity of 40.8% and a relatively high
PPV (69.0%). For the oldest group (ages 15–24), code
965.4 identified 86.8% of cases, with a 10.2% false posi-
tive rate. Combining codes 965.4 and E950.0 increased
sensitivity to 89.0% but also increased the percentage of
false positives to 19.8%.
Table 4 shows the types of acetaminophen exposure or
overdose that occurred in cases that were verified by
medical record review. Among all age groups, of the 82
cases identified by code E850.4 (indicative of an acciden-
tal poisoning) 75 were unintentional acetaminophen ex-
posure or overdose and 6 were intentional. Of the 71
cases identified by E950.0, describing suicide or self-
inflicted poisoning, 1 case was unintentional and 70
(98.6%; 95% CI 92.4%, 100%) were intentional. In the
youngest age group (0–5 years), all cases who were
coded E850.4 (indicative of an accidental poisoning)
were unintentional. It is important to note, however, in
this age group all cases were unintentional; after chart
review there were no intentional cases identified, how-
ever the more specific code E850.4 was only used in 72
of the 133 cases (54.1%). In the age group of 6–14 years,
of the 29 cases that were coded E950.0 all 29 were
intentional. Finally, for the oldest age group (15–24Table 2 Characteristics of pediatric patients visiting the
emergency department for acetaminophen exposure or
overdose (n = 316 visits)
Variable No. %
Age*
0-5 years 154 48.7
6-14 years 71 22.5








*Median age for all visits: 9 years (range, 3.6 months to 21 years).years), of the 42 cases coded E950.0, which indicates sui-
cide or self-inflicted poisoning, 41 (97.6%) of them were
intentional.
Stratification by year (2005 to 2010) indicated a de-
creasing number of ED visits identified by 1 or more of
the ICD-9 codes of interest. However, the number of
cases of acetaminophen exposure or overdose, according
to the medical record review, did not change signifi-
cantly over the period studied, suggesting that coding
procedures became more efficient over time.
Discussion and conclusion
We selected records of ED visits using selected ICD-9
codes, and from these, cases in which acetaminophen
exposure or overdose was suspected or known were
identified after a thorough review of medical records.
Review of the medical records used in our study showed
that 316 out of the 1,215 ED visits identified by the
ICD-9 codes of interest (26.0%) were related to acet-
aminophen exposure or overdose, which would result in
a 3:1 ratio of false positive cases. However, when we
included in our analysis only the codes with a PPV of at
least 50% to avoid a large number of false positives, we
captured only 87.0% of cases of acetaminophen exposure
or overdose. This suggests that different strategies might
be appropriate in different situations when using ICD-9
codes to identify rates of acetaminophen exposure or
overdose in pediatric patients. In our analysis, the most
cases of acetaminophen exposure or overdose for all
ages considered together were identified using the com-
bination of codes 965.4 (poisoning by aromatic analgesic,
NEC) or E950.0 (suicide and self-inflicted poisoning by
analgesics, antipyretics, and antirheumatics), with a sen-
sitivity of 87.0%, although this combination of codes also
yielded a 13.8% false positive rate. For children less than
6 years old, code 965.4 captured 86.4% of cases, with a
very low proportion of false positives (5.0%). It is import-
ant to recognize that although some strategies are effi-
cient in capturing the most cases, these strategies may
also result in a significant number of misclassified cases.
It is also important to note all cases coded with 965.4
were also coded E850.4, indicating accidental poisoning.
For this reason, using the combination logic of code
965.4 in addition to E850.4 and E950.0 resulted in the
same sensitivity as using 965.4 and E950.0 alone.
On the other hand, some studies may require high
specificity, such as case–control studies in which cer-
tainty about the relevance of the selected cases is im-
portant. Under these circumstances, the best code to
use, according to our analysis, was 965.4, which resulted
in a 7.2% false positive rate for all ages combined (5.0%
for 0–5 years, 8.1% for 6–14 years, and 10.2% for 15–24
years); and sensitivity was 85.1% overall (86.4% for 0–5
years, 80.3% for 8–14 years, and 86.8% for 15–24 years).
Table 3 Sensitivity, positive predictive value (PPV), and percentage of false positives identified by selected
International Classification of Disease (ICD-9) codes* used to document emergency department (ED) visits for
acetaminophen exposure or overdose, stratified by age group
Age category (Years)
(Number of cases)










965.4 290 269 85.1% 92.8% 7.2%
E850.4 87 82 25.9% 94.3% 5.7%
E850.7 1 1 0.3% 100.0% 0.0%
All ages E950.0 98 71 22.5% 72.4% 27.6%
(N=316) 965.4 OR E850.4 290 269 85.1% 92.8% 7.2%
965.4 OR E950.0 319 275 87.0% 86.2% 13.8%
E850.4 OR E950.0 185 153 48.4% 82.7% 17.3%
965.4, E850.4 OR E950.0 319 275 87.0% 86.2% 13.8%
Age 0-5 965.4 140 133 86.4% 95.0% 5.0%
E850.4 75 72 46.8% 96.0% 4.0%
(N=154) 965.4 OR E850.4 140 133 86.4% 95.0% 5.0%
965.4 62 57 80.3% 91.9% 8.1%
E850.3 3 2 2.8% 66.7% 33.3%
Age 6-14 E850.4 9 7 9.9% 77.8% 22.2%
(N=71) E950.0 42 29 40.8% 69.0% 31.0%
965.4 OR E850.3 65 59 83.1% 90.8% 9.2%
965.4 OR E850.4 62 57 80.3% 91.9% 8.1%
965.4 OR E950.0 78 61 85.9% 78.2% 21.8%
E850.3 OR E950.0 45 31 43.7% 68.9% 31.1%
E850.4 OR E950.0 51 36 50.7% 70.6% 29.4%
965.4, E850.3 OR E850.4 65 59 83.1% 90.8% 9.2%
965.4, E850.3 OR E950.0 81 63 88.7% 77.8% 22.2%
965.4, E850.4 OR E950.0 78 61 85.9% 78.2% 21.8%
E850.3 OR E850.4 OR E950.0 54 38 53.5% 70.4% 29.6%
965.4, E850.3, E850.4 OR
E950.0
81 63 88.7% 77.8% 22.2%
965.4 88 79 86.8% 89.8% 10.2%
Age 15-24 E850.4 3 3 3.3% 100.0% 0.0%
(N=91) E950.0 56 42 46.2% 75.0% 25.0%
965.4 OR E850.4 88 79 86.8% 89.8% 10.2%
965.4 OR E950.0 101 81 89.0% 80.2% 19.8%
E850.4 OR E950.0 59 45 49.5% 76.3% 23.7%
965.4, E850.4 OR E950.0 101 81 89.0% 80.2% 19.8%
*ICD-9 codes: 965.4: poisoning by aromatic analgesics, not elsewhere classified; E850.3: accidental poisoning by salicylates; E850.4: accidental poisoning by
aromatic analgesics, not elsewhere classified; E850.7: accidental poisoning by other nonnarcotic analgesics; E950.0: suicide and self-inflicted poisoning by
analgesics, antipyretics, and antirheumatics.
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identify circumstantial subgroups of pediatric patients
exposed to acetaminophen. For example, for identifying ED
visits for young children unintentionally exposed to acet-
aminophen, using both code 965.4 and accidental codes,
such as E850.4 and/or E850.7, maximized sensitivity and
PPV. Similarly, for identifying ED visits related tointentional acetaminophen exposure, using codes 950.0 (for
suicide or self-inflicted poisoning) and 965.4 in the search
led to the most precise identification of cases of interest. To
the best of our knowledge, this is the first study to examine
the validity of ICD-9 codes used in an ED administrative
database to identify potential exposure to or overdose of
acetaminophen products in a pediatric population.
Table 4 Type of acetaminophen exposure or overdose that occurred with each International Classification of Disease
(ICD-9) code used to document the emergency department (ED) visit, by age group
Age category Description ICD-9
code




Illicit unintended use, N
(%; 95% CI)
Total N=1,215 N=316 N=172 N=139 N=5
Poisoning 965.4 290 269 146 (54.3; 48.1-60.3) 119 (44.2; 38.2-50.4) 4 (1.5; 0.4-3.8)
All ages Accidental E850.4 87 82 75 (91.5; 83.2-96.5) 6 (7.3; 2.7-15.2) 1 (1.2; 0.0-6.6)
(N=316) Accidental E850.7 1 1 1 (100.0; 2.5-100.0) 0 (0.0) 0 (0)
Suicide/self-inflicted E950.0 98 71 1 (1.4; 0.0-7.6) 70 (98.6; 92.4-100.0) 0 (0)
Age 0-5 Poisoning 965.4 140 133 133 (100; 97.3-100.0) 0 (0) 0 (0)
(N=154) Accidental E850.4 75 72 72 (100; 95.0-100.0) 0 (0) 0 (0)
Poisoning 965.4 62 57 8 (14.0; 6.3-25.8) 47 (82.5; 70.1-91.3) 2 (3.5; 0.4-12.1)
Age 6-14 Accidental E850.3 3 2 1 (50.0; 1.3-98.7) 1 (50.0; 1.3-98.7) 0 (0)
(N=71) Accidental E850.4 9 7 3 (42.9; 9.9-81.6) 4 (57.1; 18.4-90.1) 0 (0)
Suicide/self-inflicted E950.0 42 29 0 (0) 29 (100; 88.1-100.0) 0 (0)
Age 15-24 Poisoning 965.4 88 79 5 (6.3; 2.1-14.2) 72 (91.1; 82.6-96.4) 2 (2.5; 0.3-8.8)
(N=91) Accidental E850.4 3 3 0 (0) 2 (66.7; 9.4; 99.2) 1 (33.3; 0.8-90.6)
Suicide/self-inflicted E950.0 56 42 1 (2.4; 0.1-12.6) 41 (97.6; 87.4-99.9) 0 (0)
CI confidence intervals; Boldface type indicates codes who’s codes correctly identified intention type.
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visits is a result of acetaminophen exposure or overdose
within the pediatric population. Previous studies have
used ICD-9 codes to evaluate national trends in
admissions for acetaminophen exposure in adults [10].
The National Hospital Ambulatory Care Survey, Na-
tional Hospital Discharge Survey, and the Centers for
Disease Control’s database of mortality all used ICD-9
code 965.4 to identify ED visits resulting from acet-
aminophen poisoning [11-13]. They also used code
E850.4 to identify ED visits resulting from accidental
poisoning by aromatic analgesics, NEC and code E850.2
to identify accidental poisoning by other opiates and
related narcotics. In addition, ICD-9 codes were used
to determine the type of acetaminophen exposure
(intentional or unintentional), particularly in the Na-
tional Hospital Discharge Survey and in national studies
examining causes of death.
In our study, the codes used for cases of unintentional
acetaminophen exposure differed from those used for
cases of intentional acetaminophen exposure or over-
dose among our oldest group of patients (15–24 years).
Code E950.0 (suicide and self-inflicted poisoning by
analgesics, antipyretics, and antirheumatics) had a
75.0% PPV, although this code alone was not capable of
capturing the majority of cases. These findings are con-
sistent with data from others with respect to age and
rates of intentional overdose [9]. Budnitz et al. identified
no cases of intentional overdose among children
younger than 6 years between 2006 and 2007 using data
from the NEISS, but older patients (ages 15–24 years)
had a higher rate of emergency department visits forintentional overdoses (over 45 per 100,000 individuals
per year).
We found that the number of ED admissions
documented with the codes we selected peaked in 2005
and 2007 and sharply decreased between 2008 and 2010.
However, the number of confirmed cases per year, was
consistent throughout the period studied, indicating that
misleading trends may result from the use of incorrect
diagnosis codes. From 2007 to 2010, code 965.4 was
capable of capturing 100% of cases, leaving no false
positives. Changes in coding, policy, or public awareness
may have played a part in the decreased number of ED
admissions documented with our selected codes during
2007–2010. Previous reports examining data from 2001
to 2008 showed an increase in admissions, ED visits, and
calls related to ingestions of pharmaceutical products.
Using the National Poison Data System, Bond et al.
reported a 57% increase in cases of unintentional acet-
aminophen exposure or overdose and a 71% increase in
cases of therapeutic error nationally between 2001 and
2008 [5]. These estimates may not be comparable to
those in our study because medications that include
acetaminophen were placed in a separate drug group
from those containing acetaminophen only in the
analysis.
Several limitations should be considered when inter-
preting our data. First, our findings are representative of
results from a single pediatric hospital within a specified
time range. Although we examined data from the largest
pediatric hospital in Texas, data from other hospitals
serving different areas may differ in coding practices,
and coding algorithms should be validated in additional
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assumed that all visits related to acetaminophen expos-
ure or overdose were identified by at least 1 of the codes
we selected. Due to the large amount of visits, only one
trained research assistant reviewed the medical records
and concordance statistics are not available, however, a
standardized consensus approach was used to classify
these cases. Not all true acetaminophen exposures/
overdoses might have been captured as some may not
have been assigned our selected codes, but if any, we be-
lieve this proportion would be very small given our
broad code selection, including several general codes
with low sensitivity and specificity. In interpreting our
findings it is important to note distinctions between ex-
posure and overdose. Since in most occasions ingestion
was not observed, overdose could not be confirmed.
While the clinical implications of these differences are
important, the purpose of our study was to evaluate the
value of diagnostic algorithms to identify a majority of
potential overdoses. Finally, we examined only the ICD-
9-CM coding system, which may not be comparable
with the ICD-10-CM coding system for future studies.
Despite efforts to reduce unintentional medication
exposures among children, overdose of acetaminophen
in this population continues to be a public health con-
cern. Development of prevention strategies and educa-
tional activities to reduce pediatric exposure to or
overdose of acetaminophen depends on reliable data
regarding trends in acetaminophen-related ED visits.
Data regarding ED visits related to acetaminophen ex-
posure or overdose is sparse, and detailed abstraction of
medical records can be time-consuming and costly.
Using reliable ICD-9 codes or combinations of codes
can be a useful strategy to estimate the number of acet-
aminophen exposures and overdoses in the pediatric
population. However, researchers and users must be
cognizant that approaches maximizing case identification
will also result in a significant proportion of false positive
cases, whereas strategies to identify only true positive
cases will result in an underestimate of the true burden of
acetaminophen exposure.
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